National Taiwan University Cancer Center, Taiwan
Author Profiles
Orcid
🎓 Academic and Professional Background
Dr. Ko earned his Medical Degree from NTUCM in 1995 and later completed his PhD in Clinical Medicine from the same institution. He has held prestigious leadership roles, including President of the Taiwan Society of Blood and Marrow Transplantation (2019–2022) and President of the Taiwan Society of Pharmacoeconomics and Outcome Research (2018–2023). He is also a member of the Executive Committee of the Asian-Pacific Blood and Marrow Transplantation (APBMT) Group, and currently presides over the Hematology Society of Taiwan (HST).
🏥 Designation and Institution
Assoc. Prof. Dr. Bor-Sheng Ko serves as the Director of the Department of Hematological Oncology at the National Taiwan University Cancer Center, Taiwan. He also holds dual roles as Director of the Tai-Cheng Cell Therapy Center and Associate Professor at the National Taiwan University College of Medicine (NTUCM).
🌍 Professional Memberships
Dr. Ko is actively engaged in numerous professional societies, including the Taiwan Society of Internal Medicine, Hematology Society of Taiwan, Taiwan Society of Blood and Marrow Transplantation, American Hematology Society, European Hematology Association, Asian-Pacific Bone and Marrow Transplantation Group, International Society of Pharmacoeconomics and Outcome Research, International Society of Cell Therapy, and the European Blood and Marrow Transplantation Group.
🔬 Areas of Research
Dr. Ko’s research spans hematology, hematopoietic stem cell transplantation (HSCT), pharmaco-economics, and the application of machine learning and deep learning in data science for clinical use. His interdisciplinary focus bridges traditional clinical research with cutting-edge computational methods.
📈 Research Contributions
Dr. Ko is a prominent figure in the study of hematopoietic diseases, particularly leukemia, lymphoma, and HSCT. He has recently led projects on medical databank development, big data analysis, and the integration of AI technologies—including machine learning and deep learning algorithms—into healthcare settings. A dedicated academic, Dr. Ko has published extensively in high-impact international journals, significantly advancing research in his fields of expertise.
Notable Publications📝
📝Recommendations for the treatment and management of adult B‐Cell acute lymphoblastic leukemia in Asia‐Pacific: Outcomes from a pilot initiative
Author: Zhentang Lao; Kwong Yok Lam; Yuk Man Carol Cheung; Chieh‐Lin Teng; Vivek Radhakrishnan; Dinesh Bhurani; Bor‐Sheng Ko; Yeow Tee Goh
Journal: Asia-Pacific Journal of Clinical Oncology
Year: 2024
📝Pooled analysis of pralatrexate single-agent studies in patients with relapsed/refractory peripheral T-cell lymphoma
Author: Owen A. O’Connor; Bor-Sheng Ko; Ming-Chung Wang; Dai Maruyama; Yuqin Song; Ee-Min Yeoh; Nick Manamley; Kensei Tobinai
Journal: Blood Advances
Year: 2024
📝Asia‐Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia‐Pacific region
Author: Zhentang Lao; Eric Wai Choi Tse; Suporn Chuncharunee; Yok Lam Kwong; Andrew Wei; Bor Sheng Ko; Jin Seok Kim; Soo Chin Ng; Jianxiang Wang; Yeow Tee Goh
Journal: Asia-Pacific Journal of Clinical Oncology
Year: 2023
📝A Chunking-for-Pooling Strategy for Cytometric Representation Learning for Automatic Hematologic Malignancy Classification
Author: Jeng-Lin Li; Yun-Chun Lin; Yu-Fen Wang; Sara A. Monaghan; Bor-Sheng Ko; Chi-Chun Lee
Journal: IEEE Journal of Biomedical and Health Informatics
Year: 2022
📝Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study
Author: Jun Ho Jang; Lily Wong; Bor-Sheng Ko; Sung-Soo Yoon; Katie Li; Irina Baltcheva; Prasanna Kumar Nidamarthy; Raghav Chawla; Guido Junge; Eng Soo Yap
Journal: Blood Advances
Year: 2022